If you hadn’t heard, High School DxD is back and bouncier than ever. The series made its return this month with its fourth season, and fans have been waiting to reunite with Issei and his devilish ...

T-DXd significantly improves progression-free and overall survival compared to T-DM1 in HER2-positive metastatic breast cancer, with a favorable safety profile. Real-world data show T-DXd's ...

High School DxD fans have been living in a drought since 2018, and there have been few signs that it will be ending anytime soon. Who doesn’t want more from this story? Well, the good news is that ...

Trastuzumab deruxtecan (T-DXd) is a HER2-targeting antibody–drug conjugate with a topoisomerase I inhibitor exatecan derivative (DX-8951 derivative, DXd) 1. A humanized, monoclonal anti-HER2 antibody ...

The new anime season is fast upon us, and there are so many new offerings every season that fans often do not have time for a proper refresher of their favorite shows before the new entries premiere.

The FDA has approved trastuzumab deruxtecan (T-DXd; Enhertu, Daiichi Sankyo/AstraZeneca) in combination with pertuzumab for the first-line treatment of unresectable or metastatic HER2-positive breast ...